Latest News

Protocols for first responders and harm reduction workers should be reviewed and updated to account for the increased presence of the animal tranquilizer xylazine in the illicit street drug supply, according to a new study led by researchers at the Yale School of Public Health.

This year, experts think the timing of the RSV season will be closer to the pre-pandemic normal, but case numbers will probably be anything but — that is, if people embrace newly available tools to prevent RSV.

During the course of the COVID-19 pandemic, Connecticut was credited with having one of the most comprehensive eviction moratoriums and protections in the nation.

The interest in Yale science was exciting at the American Society of Clinical Oncology (ASCO) annual meeting in June.

In a new study, researchers at the Yale School of Public Health show that infectious disease rates in the United States climbed as a direct long-term result of the marketing of OxyContin.

A new study shows that infectious disease rates in the United States climbed as a direct long-term result of the marketing of OxyContin.

Patient-advocacy groups mobilized to demand access to a controversial new drug called Relyvrio. But hasty approval comes at a cost.

It may be turning into a disease like the flu for most people, and the public health emergency ended May 10, but COVID-19 is with us year-round, and we may see a rise in numbers this summer or fall, say medical experts.

We hear so much about crime rates, opioids, and gun violence in America, but so little from our elected leaders about the poverty crisis.